about
Genetic manipulation for inherited neurodegenerative diseases: myth or reality?Prospects for Optogenetic Augmentation of Brain FunctionSynaptic remodeling of neuronal circuits in early retinal degenerationRetinal prostheses: progress toward the next generation implants.Nerve Growth Factor: A Focus on Neuroscience and TherapyPromising and delivering gene therapies for vision lossImmunology of AAV-Mediated Gene Transfer in the EyeTargeting neurons and photons for optogeneticsOptogenetic Vision Restoration Using Rhodopsin for Enhanced Sensitivity.Pulse trains to percepts: the challenge of creating a perceptually intelligible world with sight recovery technologiesOptogenetic pacing in Drosophila melanogasterAdvancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano SymposiumPhotochemical approaches to vision restorationWhat Is Next for Retinal Gene Therapy?Review: the history and role of naturally occurring mouse models with Pde6b mutationsOptogenetic Control of Mouse Outer Hair Cells.Visual BOLD Response in Late Blind Subjects with Argus II Retinal Prosthesis.Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cellsNext-generation probes, particles, and proteins for neural interfacing.Digital micromirror based near-infrared illumination system for plasmonic photothermal neuromodulationDry age-related macular degeneration: A currently unmet clinical need.Vector platforms for gene therapy of inherited retinopathies.Translational models of ocular disease.Clinical characteristics and current therapies for inherited retinal degenerationsStrategies for expanding the operational range of channelrhodopsin in optogenetic vision.Retinal output changes qualitatively with every change in ambient illuminanceRNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.Development of Animal Models of Local Retinal Degeneration.Inner retinal preservation in rat models of retinal degeneration implanted with subretinal photovoltaic arrays.Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.Optochemokine Tandem for Light-Control of Intracellular Ca2Two-Step Reactivation of Dormant Cones in Retinitis PigmentosaAAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates.Advances in Gene Therapy for Diseases of the Eye.Proceedings of the First International Optogenetic Therapies for Vision Symposium.Gene therapy approaches for the treatment of retinal disordersViral vectors for targeting the canine retina: a review.Functional rescue of cone photoreceptors in retinitis pigmentosa.Progress in gene therapy for neurological disorders.A review and update on the current status of retinal prostheses (bionic eye).
P2860
Q26752831-CC540659-979C-4D20-8EC0-BE77B32A46EFQ26774814-9DBA4846-9C89-44FE-B7EC-472FFD151DE9Q26779313-9F45FC7A-6650-4AEF-9E84-3EFB96144444Q26782911-DCFDEFD2-0F10-40A4-B329-DCFD5EA36662Q26786398-CA6800A2-2126-48A2-9E56-B68EEDB5A36FQ27007079-1736CCB1-362B-4EAE-871D-5EB8DD0802BBQ27023474-A7FD7E7B-A0E2-4218-9E59-DD4ECFD7E7D6Q27023926-45C051CD-2A32-4E89-A386-3DA348CDCCD5Q27318230-F8B52780-D238-4DF8-BE55-596314F33538Q27324112-CE29D65F-D7F4-463A-ADEC-C79C92D51F83Q27339316-E4002A75-10E2-4C7C-B8EE-D39262928699Q27694625-01B75DA9-A7CD-4CC3-AFDA-EDF892A60F0BQ28082199-44D438E7-F818-409D-A3EC-43D51449DD31Q28082800-C0E1DB99-4173-4E81-8A5E-28C9D2BD4637Q28304672-6CD4D359-600F-496B-83CE-EEEA8841FA79Q30365353-EBC197DB-7709-4F1D-A16C-B1DDFFD67B10Q30370609-28A0DDC9-1573-4AC3-852C-08BA9FD71EBDQ30612156-84E84122-41C7-4B7F-84E9-9119E7EBF5BEQ33783880-A7AF05BC-9E85-4FD6-8927-4E0798452DBCQ33824454-EE1CFBEA-58A1-41B0-ADCE-39D8FD9E67C7Q34378033-5401E819-15FB-48CC-822B-CCD7CE4DB2EDQ34561531-3B123558-14E0-47E6-BF62-866C798C27ECQ34764453-D6D52C42-F89C-4134-B6B6-DF94E7C66BADQ35045067-6387FFCB-B4F4-44AD-8009-AE5B7CC5B3CFQ35060493-D0626DD6-7EE7-4D59-9176-53A8E5F87C7FQ35114234-0D256D4E-DAD1-482B-981A-258EB1D303F8Q35156007-FEC83DBE-5786-4EDB-8581-61915852968AQ35710186-48CC99CB-1C09-421A-9FE6-0F09C7B05ED7Q36051555-5198561A-7113-43E5-934D-264D1B3AF760Q36147481-DB7CD233-B802-473B-BA5D-5000AF267DF2Q36170962-5A40AC8C-9791-42B9-89C0-8684AFCA9E0CQ36803227-A37D743D-C695-4592-8548-A530D519A39BQ36890213-045A4F52-8CEB-4D76-80F8-9DA5D73189DFQ37190609-36C0FD33-5A9F-4A88-92EF-20A8677E9480Q37386268-FE89C3A0-01B0-495B-B82E-FDB1B5048FF6Q37481357-188F1D74-6FA8-4516-B8DE-2A30439AC3E8Q38033669-E5054CE5-A01A-4EDB-AB73-1F03B0D05F98Q38098092-296A8E32-6313-4526-AD7F-32147A2C605EQ38100997-EBC498CE-D216-4CDC-B7A0-E82E281DBB31Q38187958-FB27D6BF-734D-41A8-8BA0-8762CF46D20A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optogenetic therapy for retinitis pigmentosa.
@ast
Optogenetic therapy for retinitis pigmentosa.
@de
Optogenetic therapy for retinitis pigmentosa.
@en
Optogenetic therapy for retinitis pigmentosa.
@fr
Optogenetic therapy for retinitis pigmentosa.
@nl
type
label
Optogenetic therapy for retinitis pigmentosa.
@ast
Optogenetic therapy for retinitis pigmentosa.
@de
Optogenetic therapy for retinitis pigmentosa.
@en
Optogenetic therapy for retinitis pigmentosa.
@fr
Optogenetic therapy for retinitis pigmentosa.
@nl
prefLabel
Optogenetic therapy for retinitis pigmentosa.
@ast
Optogenetic therapy for retinitis pigmentosa.
@de
Optogenetic therapy for retinitis pigmentosa.
@en
Optogenetic therapy for retinitis pigmentosa.
@fr
Optogenetic therapy for retinitis pigmentosa.
@nl
P2860
P50
P356
P1433
P1476
Optogenetic therapy for retinitis pigmentosa.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2011.155
P407
P577
2011-10-13T00:00:00Z
P5875
P6179
1036508493